Pillsbury Advises Deep Track Capital on Oversubscribed $65 Million Series B Financing for Draig Therapeutics
July 23, 2026
July 23, 2026
NEW YORK, July 23 -- Pillsbury, a law firm, issued the following news release:
* * *
Pillsbury Advises Deep Track Capital on Oversubscribed $65 Million Series B Financing for Draig Therapeutics
Pillsbury advised Deep Track Capital, a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry, in connection with its lead investment in Draig Therapeutics' oversubscribed $65 million Series B funding round. Draig Therape . . .
* * *
Pillsbury Advises Deep Track Capital on Oversubscribed $65 Million Series B Financing for Draig Therapeutics
Pillsbury advised Deep Track Capital, a Greenwich, Connecticut-based investment firm focused exclusively on the life sciences industry, in connection with its lead investment in Draig Therapeutics' oversubscribed $65 million Series B funding round. Draig Therape . . .